Presentation TCT 2015 ISAR-DESIRE 4: A Prospective Randomized Trial of Plaque Modification With a Scoring Balloon During Drug-Coated Balloon Treatment of Coronary In-Stent Restenosis Presenter: Cindy L. Grines, Robert A. Byrne October 14, 2015
Presentation TCT 2015 ISAR-DESIRE 4: A Prospective Randomized Trial of Plaque Modification With a Scoring Balloon During Drug-Coated Balloon Treatment of Coronary In-Stent Restenosis Presenter: Robert A. Byrne October 14, 2015
Presentation TCT 2015 Case Presentation Before Second-Time Treatment: Recurrent DES Restenosis Presenter: Robert A. Byrne, Stefan K. James, Wojtek Wojakowski October 11, 2015
Presentation TCT 2015 The Resurrection of Historic Therapies for Refractory Restenosis: Vascular Brachytherapy, Atherectomy, and Beyond Presenter: Robert A. Byrne, Stefan K. James, Paul S. Teirstein October 11, 2015
Presentation TCT 2015 Drug-Eluting Stent Restenosis State of the Art: Causes, Evaluation, and Treatment Presenter: Robert A. Byrne, Stefan K. James, Fernando Alfonso October 11, 2015
Presentation TCT 2015 How Was the Case Treated Presenter: Robert A. Byrne, Stefan K. James, Ehrin J. Armstrong October 11, 2015
Presentation TCT 2015 Case Presentation Before Treatment: An Unexpected and Difficult to Treat Stent Thrombosis Presenter: Robert A. Byrne, Stefan K. James, Ehrin J. Armstrong October 11, 2015
Presentation TCT 2015 Are There Differences in the Outcomes of Early, Late, and Very Late Stent Thrombosis? Presenter: Robert A. Byrne, Stefan K. James, Donald Cutlip October 11, 2015
Presentation TCT 2015 New Insights Into Neoatherosclerosis as a Frequent Common Denominator of DES Failure Presenter: Robert A. Byrne, Stefan K. James, Renu Virmani October 11, 2015
Presentation TCT 2015 Stent Thrombosis Update: Causes, Predictors, Implications, and Treatment Presenter: Robert A. Byrne, Stefan K. James October 11, 2015
Presentation TCT 2015 Debate: Are Bioabsorbable Polymers Preferable to Durable Polymers for Efficacy, Safety, or Required DAPT Duration? Yes, Eliminating the Polymer to Leave Behind a Bare-Metal Stent Surface Is a Desirable and Clinically Meaningful Goal! Presenter: Stephen G. Ellis, John A. Ormiston, Robert A. Byrne October 11, 2015
Presentation TCT 2014 Are There Meaningful Differences in Vascular Responses Between the Different Classes of Metallic Stent Technologies? Presenter: Robert A. Byrne, Didier Carrié, Giuseppe De Luca, Francesco Prati September 15, 2014
Presentation TCT 2014 FOCUS np: Clinical and Angiographic Results with a Nanoparticle-Based Siroliumus-Eluting Stent and Balloon Presenter: Robert A. Byrne, Didier Carrié, Giuseppe De Luca, Upendra Kaul September 15, 2014
Presentation TCT 2014 BioFreedom: From Pilot Results to the Leaders-Free Trial Presenter: Robert A. Byrne, Didier Carrié, Giuseppe De Luca, Philip M. Urban September 15, 2014
Presentation TCT 2014 Amphillic Sirolimus-Eluting Cre8 Technology - New Studies and Future Directions Presenter: Robert A. Byrne, Didier Carrié, Giuseppe De Luca September 15, 2014
Presentation TCT 2014 The Drug-Filled Stent: From Concept to Clinical Development Presenter: Robert A. Byrne, Didier Carrié, Giuseppe De Luca, Martin T. Rothman September 15, 2014
Presentation TCT 2014 Pro Bioabsorbable Polymer-Based Metallic DES! Presenter: Robert A. Byrne September 15, 2014
Presentation TCT 2014 Case Study: DES in a High Bleeding Risk Patient with Complex Coronary Artery Disease Presenter: Philip M. Urban, Marco Valgimigli, Christian M. Spaulding, Robert A. Byrne September 14, 2014
Presentation TCT 2014 Approach to In-Stent Restenosis in 2014: DCB or DES? Presenter: Run-Lin Gao, Jochen Wöhrle, Bruno Scheller, Robert A. Byrne September 13, 2014
Presentation TCT 2014 DCB Plus Provisional Scaffold (BRS): Technique and Clinical Results Presenter: Robert A. Byrne, Bruno Scheller, Francesco Liistro, Azeem Latib September 13, 2014